ABL Bio Inc. (KOSDAQ:298380)
80,600
+2,800 (3.60%)
May 30, 2025, 3:30 PM KST
ABL Bio Revenue
ABL Bio had revenue of 2.16B KRW in the quarter ending March 31, 2025, a decrease of -72.73%. This brings the company's revenue in the last twelve months to 27.63B, down -16.53% year-over-year. In the year 2024, ABL Bio had annual revenue of 33.40B, down -49.04%.
Revenue (ttm)
27.63B
Revenue Growth
-16.53%
P/S Ratio
141.56
Revenue / Employee
270.89M
Employees
102
Market Cap
3,911.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.40B | -32.14B | -49.04% |
Dec 31, 2023 | 65.55B | -1.75B | -2.61% |
Dec 31, 2022 | 67.30B | 61.97B | 1,162.19% |
Dec 31, 2021 | 5.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition